V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310007533 | 310004688 | 1.52 | null | null | 2013-10-02 | 2014-02-16 | Etoposide oral | N | N | 310018590 | ETOPOSIDE |
| 310007534 | 310007998 | null | 59 | Curative (C) | 2015-08-18 | 2016-01-21 | Ipilimumab | 2 | null | 310018591 | IPILIMUMAB |
| 310007535 | 310004691 | 1.6 | 73.7 | null | 2017-06-10 | 2018-02-11 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310018600 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310007536 | 310004692 | null | 93.5 | Curative (C) | 2016-02-28 | 2016-02-28 | Cisplatin 7 day | Y | N | 310018600 | CISPLATIN |
| 310007537 | 310004694 | 1.75 | null | Palliative (P) | 2016-12-24 | 2016-12-24 | Docetaxel | N | N | 310018604 | DOCETAXEL |
| 310007538 | 310004694 | 1.73 | 99.2 | Disease modification (D) | 2014-07-01 | 2014-07-01 | Rituximab | N | N | 310018604 | RITUXIMAB |
| 310007539 | 310004695 | 1.66 | 52.1 | Palliative (P) | 2015-10-20 | 2015-10-20 | Docetaxel 75mg/m2 (21 day) | 99 | N | 310018609 | DOCETAXEL |
| 310007540 | 310004696 | 1.61 | 55 | null | 2017-01-19 | 2017-01-29 | Etoposide oral | N | N | 310018613 | ETOPOSIDE |
| 310007541 | 310004696 | 1.75 | 100 | null | 2017-09-02 | 2018-04-03 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310018613 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310007542 | 310004698 | null | 48.3 | Disease modification (D) | 2016-08-27 | 2016-08-31 | CYCLOPHOSPHAMIDE | Y | N | 310018616 | CYCLOPHOSPHAMIDE |
| 310007543 | 310008004 | 1.71 | 69.6 | Palliative (P) | 2013-08-17 | 2013-09-04 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | N | 310018619 | CARBOPLATIN + ETOPOSIDE |
| 310007544 | 310004699 | 1.7 | 61.4 | Disease modification (D) | 2014-03-12 | 2014-05-23 | ESHAP | 02 | N | 310018620 | BEXAROTENE |
| 310007545 | 310004699 | null | 76 | Curative (C) | 2016-06-04 | 2016-06-15 | ALL UKALL2011 Aug BFM Cons C PegAsp | N | N | 310018620 | BEXAROTENE |
| 310007546 | 310004701 | 1.52 | 75 | Adjuvant (A) | 2015-09-01 | 2015-09-08 | ALL UKALL2011 Aug BFM Cons C PegAsp | N | Y | 310018637 | CARBOPLATIN + ETOPOSIDE |
| 310007547 | 310004702 | 1.63 | 71 | Disease modification (D) | 2018-08-05 | 2018-08-06 | ALL UKALL2011 Del Int C Reind PAsp | N | N | 310018637 | ESHAP |
| 310007548 | 310009771 | 1.77 | null | Curative (C) | 2016-02-08 | 2016-06-12 | Ipilimumab | 02 | N | 310018640 | IPILIMUMAB |
| 310007549 | 310009771 | null | 73 | Disease modification (D) | 2015-11-27 | 2016-02-07 | Docetaxel | N | N | 310018640 | DOCETAXEL |
| 310007550 | 310009771 | null | 59.7 | null | 2018-07-06 | 2018-07-08 | Ipilimumab | N | null | 310018640 | IPILIMUMAB |
| 310007551 | 310009771 | 1.73 | 74.6 | Palliative (P) | null | 2013-10-24 | CYCLOPHOSPHAMIDE | 02 | null | 310018640 | CYCLOPHOSPHAMIDE |
| 310007552 | 310004705 | 1.67 | null | Curative (C) | 2017-11-21 | 2017-12-07 | ESHAP | 02 | N | 310018649 | UKALL2011 |
| 310007553 | 310004706 | null | 68 | Palliative (P) | 2019-02-04 | 2019-03-08 | Docetaxel 75mg/m2 (21 day) | N | null | 310018650 | DOCETAXEL |
| 310007554 | 310004709 | 1.69 | 97.1 | null | 2015-09-04 | 2015-09-23 | Etoposide PBSCT Mobilisat (1.6g/m2) | N | null | 310018650 | ETOPOSIDE |
| 310007555 | 310004713 | null | 109 | Palliative (P) | 2013-05-14 | 2013-05-26 | Methotrexate intrathecal | 2 | N | 310018656 | METHOTREXATE INTRATHECAL |
| 310007556 | 310008012 | 1.76 | 68.5 | Curative (C) | 2017-07-25 | 2017-07-25 | CYCLOPHOSPHAMIDE | 2 | N | 310018656 | CYCLOPHOSPHAMIDE |
| 310007557 | 310008012 | 0 | 61.4 | Palliative (P) | 2015-03-27 | 2015-03-28 | Docetaxel 75mg/m2 (21 day) | N | N | 310018656 | DOCETAXEL |
| 310007558 | 310008012 | 1.75 | 59.3 | Palliative (P) | 2014-10-23 | 2014-11-04 | CYCLOPHOSPHAMIDE + FILGRASTIM | N | N | 310018656 | CYCLOPHOSPHAMIDE |
| 310007559 | 310004714 | 1.5 | 76 | Curative (C) | 2012-04-11 | 2015-06-29 | Cisplatin + Radiotherapy | N | N | 310018675 | CISPLATIN + RT |
| 310007560 | 310008013 | 1.49 | 94 | Curative (C) | 2016-11-15 | 2016-12-08 | CHOP R | N | null | 310018680 | CHOP R |
| 310007561 | 310004717 | 1.73 | null | Curative (C) | null | 2013-09-23 | Methotrexate intrathecal | N | null | 310018685 | METHOTREXATE INTRATHECAL |
| 310007562 | 310004721 | 1.8 | 74 | Palliative (P) | 2014-08-25 | 2015-06-08 | Cisplatin | N | N | 310018687 | CISPLATIN |
| 310007563 | 310004722 | 1.76 | 90.9 | Palliative (P) | 2014-05-17 | 2014-05-20 | Rituximab | N | N | 310018688 | RITUXIMAB |
| 310007564 | 310004725 | 1.67 | null | Curative (C) | 2016-10-12 | 2016-10-17 | Rituximab | N | N | 310018688 | RITUXIMAB |
| 310007565 | 310004726 | 1.81 | 72.1 | Palliative (P) | 2016-04-10 | 2016-04-12 | CYCLOPHOSPHAMIDE | 02 | N | 310018695 | CYCLOPHOSPHAMIDE |
| 310007566 | 310008018 | 1.54 | 76 | Palliative (P) | 2017-08-03 | 2017-11-09 | Cyclophosphamide oral | N | N | 310018697 | CYCLOPHOSPHAMIDE |
| 310007567 | 310004729 | 1.68 | 73.9 | null | null | 2016-06-12 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310018698 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310007568 | 310004729 | 1.73 | 91.7 | null | 2014-05-06 | 2014-05-28 | Bexarotene | 02 | N | 310018698 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310007569 | 310004731 | 1.59 | 65.699 | Palliative (P) | 2014-03-08 | 2014-03-08 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 310018701 | UKALL2011 |
| 310007570 | 310004732 | 1.78 | 112.1 | Palliative (P) | 2014-01-29 | 2014-08-04 | Docetaxel+Gemcitabine (no prior RT) | N | N | 310018705 | DOCETAXEL + GEMCITABINE |
| 310007571 | 310004733 | null | 78.2 | Not known (9) | 2016-06-13 | 2016-07-08 | Carboplatin + Etoposide iv&po | N | N | 310018713 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310007572 | 310004734 | 1.53 | 76 | Disease modification (D) | 2015-03-22 | 2015-03-22 | Methotrexate intrathecal | N | null | 310018717 | METHOTREXATE INTRATHECAL |
| 310007573 | 310004736 | 1.89 | 71 | Palliative (P) | 2015-05-26 | 2015-07-11 | CHOP R - 21 days | N | null | 310018718 | CHOP R |
| 310007574 | 310004737 | 1.77 | 79.2 | Neo-adjuvant (N) | null | 2016-11-21 | Docetaxel | 2 | null | 310018720 | DOCETAXEL |
| 310007575 | 310004738 | null | 63 | Curative (C) | 2016-02-27 | 2016-03-24 | Methotrexate intrathecal | 02 | null | 310018723 | METHOTREXATE INTRATHECAL |
| 310007576 | 310004740 | 1.74 | 79.5 | Curative (C) | 2017-09-27 | 2017-10-04 | Cisplatin + Radiotherapy | N | N | 310018723 | CISPLATIN + RT |
| 310007577 | 310004741 | 1.74 | 95 | null | 2017-12-19 | 2017-12-22 | CYCLOPHOSPHAMIDE | 02 | N | 310018729 | CYCLOPHOSPHAMIDE |
| 310007578 | 310004741 | 1.64 | null | Palliative (P) | 2015-06-03 | 2015-09-23 | Bexarotene | N | null | 310018729 | ESHAP |
| 310007579 | 310011258 | null | 91 | Curative (C) | 2018-01-03 | 2018-01-03 | Methotrexate intrathecal | 2 | N | 310018733 | METHOTREXATE INTRATHECAL |
| 310007580 | 310004743 | 1.67 | 81.6 | Palliative (P) | 2018-01-03 | 2018-05-06 | Docetaxel+Gemcitabine (no prior RT) | N | N | 310018733 | DOCETAXEL + GEMCITABINE |
| 310007581 | 310004745 | null | 96.4 | Palliative (P) | null | 2015-08-12 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310018736 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310007584 | 310004749 | 1.7 | 106.3 | Disease modification (D) | 2015-04-01 | 2015-04-01 | CYCLOPHOSPHAMIDE + FILGRASTIM | N | null | 310018744 | CYCLOPHOSPHAMIDE |